title: [Protease and reverse transcriptase genetic polymorphism in HIV type 1 subtype A variants predominating in cis countries].
abstract: To define frequencies of drug resistance mutations among HIV-1 variants circulating within the territory of Russia, subtype A HIV-1 nucleotide sequences encoding protease and reverse transcriptase were analyzed. The analysis was carried out in 141 antiretroviral-naive individuals. Low frequency (less than 1%) of primary drug resistance mutations was shown. However, high frequencies of secondary mutations V77I in protease and A62V in RT (67% H 63%, respectively) linked to each other in most cases were observed. The HIV-1 isolates bearing both substitutions (MutV77I/A62V) were also characterized by the presence of several synonymous mutations, suggesting common origin for these viruses. HIV Biochip Hybridization microarray and/or Restriction fragment-length polymorphism analyses were performed to characterize gene pol polymorphism in additional 178 subtype A HIV-1 isolates. Among total 319 samples studied, Mutv77IA62V variant accounted for 56%, and was found to predominate in Russia in terms of both its geographical distribution and number of cases caused. Moreover, these viruses were prevalent in the regions known to have highest incidence of HIV-1 infection (Irkutsk, Samara, and Moscow regions). In addition, three other variants were found: viruses not containing the substitutions V77I or A62V, and variants bearing only one of them. Evolutional relationships between all four HIV-1 variants, as well as potential impact of the gene pol polymorphism on HIV-1 replicative fitness and drug resistance development are discussed.
authors.forename: A L
authors.initials: AL
authors.lastname: Sukhanova
authors.forename: N I
authors.initials: NI
authors.lastname: Rudinskiĭ
authors.forename: E V
authors.initials: EV
authors.lastname: Bogoslovskaia
authors.forename: A I
authors.initials: AI
authors.lastname: Kruglova
authors.forename: L Iu
authors.initials: LIu
authors.lastname: Bashkirova
authors.forename: G M
authors.initials: GM
authors.lastname: Tsyganova
authors.forename: G A
authors.initials: GA
authors.lastname: Shipulin
authors.forename: E V
authors.initials: EV
authors.lastname: Kazennova
authors.forename: Iu I
authors.initials: IuI
authors.lastname: Alikina
authors.forename: S Ia
authors.initials: SIa
authors.lastname: Zverev
authors.forename: A E
authors.initials: AE
authors.lastname: Grishechkin
authors.forename: V V
authors.initials: VV
authors.lastname: Pokrovskiĭ
authors.forename: M R
authors.initials: MR
authors.lastname: Bobkova
authors.forename: A F
authors.initials: AF
authors.lastname: Bobkov
mesh_terms: D019943:Amino Acid Substitution; D017517:Commonwealth of Independent States; D024882:Drug Resistance, Viral / Q000235:genetics; D016679:Genome, Viral / Q000235:genetics*; D015658:HIV Infections / Q000188:drug therapy / Q000235:genetics*; D016333:HIV Protease / Q000235:genetics*; D054303:HIV Reverse Transcriptase / Q000235:genetics*; D015497:HIV-1 / Q000235:genetics*; D017354:Point Mutation; D011110:Polymorphism, Genetic
chemical_list: D054303:HIV Reverse Transcriptase; D016333:HIV Protease